// November 27, 2023
Q&A: Building a More Resilient Medicines Supply Chain
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
The development of generic versions of innovator medicines is a global public health need.
When a problem puts millions of lives at risk, costs economies billions of dollars and undermines
UPDATED: May 15, 2019